226 related articles for article (PubMed ID: 35999217)
21. Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a Hepatokine.
Hashimoto O; Funaba M; Sekiyama K; Doi S; Shindo D; Satoh R; Itoi H; Oiwa H; Morita M; Suzuki C; Sugiyama M; Yamakawa N; Takada H; Matsumura S; Inoue K; Oyadomari S; Sugino H; Kurisaki A
Cell Rep; 2018 Oct; 25(5):1193-1203. PubMed ID: 30380411
[TBL] [Abstract][Full Text] [Related]
22. cDNA cloning and expression of human activin betaE subunit.
Hashimoto O; Tsuchida K; Ushiro Y; Hosoi Y; Hoshi N; Sugino H; Hasegawa Y
Mol Cell Endocrinol; 2002 Aug; 194(1-2):117-22. PubMed ID: 12242034
[TBL] [Abstract][Full Text] [Related]
23. Associations between body composition, fat distribution and metabolic consequences of excess adiposity with severe COVID-19 outcomes: observational study and Mendelian randomisation analysis.
Gao M; Wang Q; Piernas C; Astbury NM; Jebb SA; Holmes MV; Aveyard P
Int J Obes (Lond); 2022 May; 46(5):943-950. PubMed ID: 35031696
[TBL] [Abstract][Full Text] [Related]
24. Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk.
Pigeyre M; Sjaarda J; Mao S; Chong M; Hess S; Yusuf S; Gerstein H; Paré G
Diabetes Care; 2019 Sep; 42(9):1800-1808. PubMed ID: 31235487
[TBL] [Abstract][Full Text] [Related]
25. Adiposity is associated with DNA methylation profile in adipose tissue.
Agha G; Houseman EA; Kelsey KT; Eaton CB; Buka SL; Loucks EB
Int J Epidemiol; 2015 Aug; 44(4):1277-87. PubMed ID: 25541553
[TBL] [Abstract][Full Text] [Related]
26. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
27. Germline mutations of inhibins in early-onset ovarian epithelial tumors.
Tournier I; Marlin R; Walton K; Charbonnier F; Coutant S; Théry JC; Charbonnier C; Spurrell C; Vezain M; Ippolito L; Bougeard G; Roman H; Tinat J; Sabourin JC; Stoppa-Lyonnet D; Caron O; Bressac-de Paillerets B; Vaur D; King MC; Harrison C; Frebourg T
Hum Mutat; 2014 Mar; 35(3):294-7. PubMed ID: 24302632
[TBL] [Abstract][Full Text] [Related]
28. Harnessing tissue-specific genetic variation to dissect putative causal pathways between body mass index and cardiometabolic phenotypes.
Leyden GM; Shapland CY; Davey Smith G; Sanderson E; Greenwood MP; Murphy D; Richardson TG
Am J Hum Genet; 2022 Feb; 109(2):240-252. PubMed ID: 35090585
[TBL] [Abstract][Full Text] [Related]
29. Brown adipose tissue is associated with healthier body fat distribution and metabolic benefits independent of regional adiposity.
Wibmer AG; Becher T; Eljalby M; Crane A; Andrieu PC; Jiang CS; Vaughan R; Schöder H; Cohen P
Cell Rep Med; 2021 Jul; 2(7):100332. PubMed ID: 34337558
[TBL] [Abstract][Full Text] [Related]
30. Relationship of absence or presence of a family history of diabetes to body weight and body fat distribution in type 2 diabetes.
Fujimoto WY; Leonetti DL; Newell-Morris L; Shuman WP; Wahl PW
Int J Obes; 1991 Feb; 15(2):111-20. PubMed ID: 2040548
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes.
Albrechtsen A; Grarup N; Li Y; Sparsø T; Tian G; Cao H; Jiang T; Kim SY; Korneliussen T; Li Q; Nie C; Wu R; Skotte L; Morris AP; Ladenvall C; Cauchi S; Stančáková A; Andersen G; Astrup A; Banasik K; Bennett AJ; Bolund L; Charpentier G; Chen Y; Dekker JM; Doney AS; Dorkhan M; Forsen T; Frayling TM; Groves CJ; Gui Y; Hallmans G; Hattersley AT; He K; Hitman GA; Holmkvist J; Huang S; Jiang H; Jin X; Justesen JM; Kristiansen K; Kuusisto J; Lajer M; Lantieri O; Li W; Liang H; Liao Q; Liu X; Ma T; Ma X; Manijak MP; Marre M; Mokrosiński J; Morris AD; Mu B; Nielsen AA; Nijpels G; Nilsson P; Palmer CN; Rayner NW; Renström F; Ribel-Madsen R; Robertson N; Rolandsson O; Rossing P; Schwartz TW; ; Slagboom PE; Sterner M; ; Tang M; Tarnow L; Tuomi T; van't Riet E; van Leeuwen N; Varga TV; Vestmar MA; Walker M; Wang B; Wang Y; Wu H; Xi F; Yengo L; Yu C; Zhang X; Zhang J; Zhang Q; Zhang W; Zheng H; Zhou Y; Altshuler D; 't Hart LM; Franks PW; Balkau B; Froguel P; McCarthy MI; Laakso M; Groop L; Christensen C; Brandslund I; Lauritzen T; Witte DR; Linneberg A; Jørgensen T; Hansen T; Wang J; Nielsen R; Pedersen O
Diabetologia; 2013 Feb; 56(2):298-310. PubMed ID: 23160641
[TBL] [Abstract][Full Text] [Related]
32. A linkage and exome study of multiplex families with bipolar disorder implicates rare coding variants of ANK3 and additional rare alleles at 10q11-q21.
Toma C; Shaw AD; Heath A; Pierce KD; Mitchell PB; Schofield PR; Fullerton JM
J Psychiatry Neurosci; 2021 Mar; 46(2):E247-E257. PubMed ID: 33729739
[TBL] [Abstract][Full Text] [Related]
33. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
[TBL] [Abstract][Full Text] [Related]
34. Beta A versus beta B: is it merely a matter of expression?
Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
[TBL] [Abstract][Full Text] [Related]
35. Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes.
Tanaka D; Nagashima K; Sasaki M; Funakoshi S; Kondo Y; Yasuda K; Koizumi A; Inagaki N
Mol Genet Metab; 2013 May; 109(1):112-7. PubMed ID: 23499280
[TBL] [Abstract][Full Text] [Related]
36. Segregation of a latent high adiposity phenotype in families with a history of type 2 diabetes mellitus implicates rare obesity-susceptibility genetic variants with large effects in diabetes-related obesity.
Jenkins AB; Batterham M; Samocha-Bonet D; Tonks K; Greenfield JR; Campbell LV
PLoS One; 2013; 8(8):e70435. PubMed ID: 23950934
[TBL] [Abstract][Full Text] [Related]
37. The genetics of fat distribution.
Schleinitz D; Böttcher Y; Blüher M; Kovacs P
Diabetologia; 2014 Jul; 57(7):1276-86. PubMed ID: 24632736
[TBL] [Abstract][Full Text] [Related]
38. Development and characterisation of an antibody for the immunohistochemical detection of inhibin/activin betaE (betaE) in normal human ovarian and placental tissue.
Mylonas I; Makovitzky J; Shabani N; Gingelmaier A; Dian D; Kuhn C; Schulze S; Kunze S; Jeschke U; Friese K
Acta Histochem; 2009; 111(4):366-71. PubMed ID: 19195688
[TBL] [Abstract][Full Text] [Related]
39. Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study.
Lange LA; Norris JM; Langefeld CD; Nicklas BJ; Wagenknecht LE; Saad MF; Bowden DW
Int J Obes (Lond); 2005 May; 29(5):449-57. PubMed ID: 15672110
[TBL] [Abstract][Full Text] [Related]
40. Inhibin betaB expression in murine adipose tissue and its regulation by leptin, insulin and dexamethasone.
Hoggard N; Cruickshank M; Moar KM; Barrett P; Bashir S; Miller JD
J Mol Endocrinol; 2009 Oct; 43(4):171-7. PubMed ID: 19491194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
